Active immunotherapy trials on acute lymphoid leukemia lymphosarcoma and acute myeloid leukemia
- 31 May 1977
- journal article
- clinical trial
- Published by Elsevier
- Vol. 13 (4-5) , 445-455
- https://doi.org/10.1016/0014-2964(77)90101-3
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Attempts at non-specific cell-mediated immunorestoration of immunodepressed cancer patients with BCGCancer Immunology, Immunotherapy, 1976
- CHEMOTHERAPY AND B.C.G. IN ACUTE LYMPHOCYTIC LEUKqMIAThe Lancet, 1975
- CHEMOIMMUNOTHERAPY OF ADULT ACUTE LEUKÆMIA PROLONGATION OF REMISSION IN MYELOBLASTIC LEUKÆMIA WITH B.C.G.The Lancet, 1974
- PROLONGING REMISSION IN MYELOBLASTIC LEUKÆMIA BY TICE-STRAIN BACILLUS CALMETTE-GUÉRINThe Lancet, 1974
- A second comparative trial of remission induction (by cytosine arabinoside given every 12 hours, or C.A.R. and thioguanine, or C.A.R. and daunorubicine) and maintenance therapy (by C.A.R. or methylgag) in acute myeloid leukaemiaPublished by Elsevier ,1974
- Treatment of Acute Lymphoblastic Leukaemia: PRELIMINARY REPORT BY THE LEUKAEMIA COMMITTEE AND THE WORKING PARTY ON LEUKAEMIA IN CHILDHOODBMJ, 1971
- Active immunotherapy of L1210 leukaemia applied after the graft of tumour cells.British Journal of Cancer, 1969
- ACTIVE IMMUNOTHERAPY FOR ACUTE LYMPHOBLASTIC LEUKÆMIAThe Lancet, 1969